Home / Current Issue / Paper 1725214
A Review on Evaluation of Plumbago Zeylanica Topical Preparation
Subject area: Biological & Medical Sciences · Area of research: Herbal Formulation and Pharmaceutics
Abstract
Plumbago zeylanica L. (Chitrak) has been used within traditional medicine for many years. Due to it being reported to have antimicrobial, anti-inflammatory, antioxidant and wound-healing effects there has been an interest in creating topical products from this plant. Plumbago zeylanica contains various phytochemicals such as naphthoquinones, flavonoids, tannins, terpenoids and sterols. However, plumbagin in particular has attracted interest due to its biological activity. However, even though promising results were found using extracts of the plant or isolated compounds, this does not guarantee that the final product will be safe and effective. This narrative review will discuss the scientific reasoning behind creating a topical product from Plumbago zeylanica. This includes looking at aspects such as identification, standardisation, appearance, pH, rheology, homogeneity, release, skin distribution, biological activity, safety and stability. Whilst there is evidence to suggest further investigation could be done, especially regarding wound healing, the evidence is mainly pre-clinical. Future development should focus on creating a reproducible formulation, appropriate controls and ensuring that the biological activity relates to skin tolerance. Clinical trials will be needed before making definite claims about the therapeutic effect.
Keywords
Plumbago zeylanica, Chitrak, plumbagin, topical formulation, herbal formulation, wound healing, skin safety
References
[1] Shukla B, Saxena S, Usmani S, Kushwaha P. Phytochemistry and pharmacological studies of Plumbago zeylanica L.: a medicinal plant review. Clin Phytosci. 2021;7:34. https://doi.org/10.1186/s40816-021-00271-7.
[2] Petrocelli G, Marrazzo P, Bonsi L, Facchin F, Alviano F, Canaider S. Plumbagin, a natural compound with several biological effects and anti-inflammatory properties. Life (Basel). 2023;13(6):1303. https://doi.org/10.3390/life13061303.
[3] Padhye S, Dandawate P, Yusufi M, Ahmad A, Sarkar FH. Perspectives on medicinal properties of plumbagin and its analogs. Med Res Rev. 2012;32(6):1131–58. https://doi.org/10.1002/med.20235.
[4] Tilak JC, Adhikari S, Devasagayam TPA. Antioxidant properties of Plumbago zeylanica, an Indian medicinal plant and its active ingredient, plumbagin. Redox Rep. 2004;9(4):219–27. https://doi.org/10.1179/135100004225005976.
[5] Sheeja E, Joshi SB, Jain DC. Bioassay-guided isolation of anti-inflammatory and antinociceptive compound from Plumbago zeylanica leaf. Pharm Biol. 2010;48(4):381–7. https://doi.org/10.3109/13880200903156424.
[6] Kodati DR, Burra S, Kumar GP. Evaluation of wound healing activity of methanolic root extract of Plumbago zeylanica L. in Wistar albino rats. Asian J Plant Sci Res. 2011;1(2):26–34.
[7] Ahmad I, Mehmood Z, Mohammad F. Screening of some Indian medicinal plants for their antimicrobial properties. J Ethnopharmacol. 1998;62(2):183–93.
[8] Franz TJ. Percutaneous absorption on the relevance of in vitro data. J Invest Dermatol. 1975;64(3):190–5. https://doi.org/10.1111/1523-1747.ep12533356.
[9] Shah VP, Elkins JS, Williams RL. Evaluation of the test system used for in vitro release of drugs for topical dermatological drug products. Pharm Dev Technol. 1999;4(3):377–85. https://doi.org/10.1081/PDT-100101373.
[10] Higuchi T. Rate of release of medicaments from ointment bases containing drugs in suspension. J Pharm Sci. 1961;50(10):874–5. https://doi.org/10.1002/jps.2600501018.
[11] Organisation for Economic Co-operation and Development. Test No. 428: skin absorption: in vitro method. OECD guidelines for the testing of chemicals, section 4. Paris: OECD Publishing; 2004. https://doi.org/10.1787/9789264071087-en.
[12] US Food and Drug Administration. In vitro release test studies for topical drug products submitted in ANDAs: draft guidance for industry [Internet]. Silver Spring (MD): US Food and Drug Administration; 2022 Oct [cited 2026 Oct 29]. Available from: https://www.fda.gov/media/162476/download
[13] US Food and Drug Administration. Physicochemical and structural (Q3) characterization of topical drug products submitted in ANDAs: guidance for industry [Internet]. Silver Spring (MD): US Food and Drug Administration; 2026 Mar [cited 2026 Oct 29]. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/physicochemical-and-structural-q3-characterization-topical-drug-products-submitted-andas
[14] World Health Organization. Quality control methods for herbal materials. Geneva: World Health Organization; 2011.
[15] World Health Organization. WHO guidelines for assessing quality of herbal medicines with reference to contaminants and residues. Geneva: World Health Organization; 2007.
[16] World Health Organization. WHO good manufacturing practices for the manufacture of herbal medicines. In: WHO Expert Committee on Specifications for Pharmaceutical Preparations: fifty-second report. Geneva: World Health Organization; 2018. Annex 2. WHO technical report series; no. 1010.
[17] International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. Validation of analytical procedures Q2(R2) [Internet]. Geneva: ICH; 2023 [cited 2026 Oct 29]. Available from: https://database.ich.org/sites/default/files/ICH_Q2(R2)_Guideline_2023_1130.pdf
[18] International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Stability testing of new drug substances and products Q1A(R2) [Internet]. Geneva: ICH; 2003 [cited 2026 Oct 29]. Available from: https://database.ich.org/sites/default/files/Q1A_R2_Guideline.pdf
[19] Organisation for Economic Co-operation and Development. Test No. 439: in vitro skin irritation: reconstructed human epidermis test method. OECD guidelines for the testing of chemicals, section 4. Paris: OECD Publishing; 2025. https://doi.org/10.1787/9789264242845-en.
[20] Organisation for Economic Co-operation and Development. Test No. 431: in vitro skin corrosion: reconstructed human epidermis (RHE) test method. OECD guidelines for the testing of chemicals, section 4. Paris: OECD Publishing; 2025. https://doi.org/10.1787/9789264264618-en.
How to cite this paper
@article{1725214,
author = {Ghawit Rutuja Randhirkumar , Futane Sakshi , More Gayatri , Suryawanshi Vaishnavi , Bandgar P. S.},
title = {A Review on Evaluation of Plumbago Zeylanica Topical Preparation},
journal = {Iconic Research And Engineering Journals},
year = {2026},
volume = {10},
number = {5},
pages = {3013-3021},
issn = {2456-8880},
url = {https://www.irejournals.com/formatedpaper/1725214.pdf},
abstract = {Plumbago zeylanica L. (Chitrak) has been used within traditional medicine for many years. Due to it being reported to have antimicrobial, anti-inflammatory, antioxidant and wound-healing effects there has been an interest in creating topical products from this plant. Plumbago zeylanica contains various phytochemicals such as naphthoquinones, flavonoids, tannins, terpenoids and sterols. However, plumbagin in particular has attracted interest due to its biological activity. However, even though promising results were found using extracts of the plant or isolated compounds, this does not guarantee that the final product will be safe and effective. This narrative review will discuss the scientific reasoning behind creating a topical product from Plumbago zeylanica. This includes looking at aspects such as identification, standardisation, appearance, pH, rheology, homogeneity, release, skin distribution, biological activity, safety and stability. Whilst there is evidence to suggest further investigation could be done, especially regarding wound healing, the evidence is mainly pre-clinical. Future development should focus on creating a reproducible formulation, appropriate controls and ensuring that the biological activity relates to skin tolerance. Clinical trials will be needed before making definite claims about the therapeutic effect.},
keywords = {Plumbago zeylanica, Chitrak, plumbagin, topical formulation, herbal formulation, wound healing, skin safety},
month = {November},
}